Lv44
680 积分 2025-07-28 加入
Do sigma-1 receptor agonists offer therapeutic promise for Alzheimer’s disease?
9天前
已完结
Evaluating emerging amyloid-β centric drugs for the treatment of Alzheimer's disease
9天前
已完结
Pooled analysis of phase III with entacapone in Parkinson's disease
21天前
已完结
Projected lecanemab wastage from vial discard: Simulation based on Japanese interim post-marketing surveillance summary statistics
21天前
已完结
White matter abnormalities in Alzheimer's disease: Implications for pathophysiology, diagnosis, and treatment
22天前
已完结
Tramiprosate, the Active Agent of ALZ-801, Modulates Amyloidogenic APP Processing and Tau Phosphorylation in a Cellular Model of Alzheimer's Disease
23天前
已关闭
Comparison of in vitro activity of the nitroimidazoles delamanid and pretomanid against multidrug-resistant and extensively drug-resistant tuberculosis
27天前
已完结
The Indiana University Brain Health Program to deliver amyloid‐targeted therapy to Alzheimer's disease patients
1个月前
已完结
Therapeutic Angiogenesis using Hepatocyte Growth Factor (HGF)
1个月前
已完结
Lecanemab treatment improves B cell subpopulation immune homeostasis in patients with Alzheimer's disease
1个月前
已关闭
皖公网安备34019202002308
